Jubilant Pharmova Ltd
NSE: JUBLPHARMA BSE: 530019
₹1021
(1.27%)
Thu, 14 May 2026, 00:02 pm
Market Cap160.65B
PE Ratio37.47
Dividend0.50
Jubilant Pharmova Ltd About
Jubilant Pharmova in radiopharma, allergy immunotherapy, contract development and manufacturing of sterile injectable, generics, contract research development and manufacturing and proprietary novel drugs businesses.
Industry
Pharmaceuticals - Indian - Bulk Drugs
Founded
1978
Headquarters
CEO
Shyam S Bhartia
Employees
Contact
Website
http://www.jubl.com
investors@jubl.com
Phone
91-5924-267200
Location
Bhartiagram Gajraula, , Amroha, Uttar Pradesh, 244223
Executives
Open Your Free Demat Account Now!
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800